Design and rationale of gulf documentation of ambulatory sick patients with heart failure (Gulf DYSPNEA) registry

Abstract

Aim: The aim of this study is to describe the clinical characteristics of ambulatory patients with chronic heart failure (HF) in the Arabian Gulf and to examine several aspects including types of HF, causes, and adherence to management guidelines. Methods: Gulf documentation of ambulatory sick patients with HF (Gulf DYSPNEA) registry is a multicenter, cross-sectional study, recruiting adult ambulatory HF patients from 24 hospitals in five Arabian Gulf countries. Consecutive patients are recruited prospectively from participating clinics with no follow-up data collection. Recruitment started on November 07, 2016 and will stop when 3,500 patients are enrolled in this study. Collected data explore demographics, baseline patient characteristics, symptoms, previous medical history, comorbidities, physical signs, presenting electrocardiogram, echocardiographic findings, types of HF, and management. Conclusion: This registry is expected to provide useful data on several important aspects and features of ambulatory patients with chronic HF in Arabian Gulf countries. The trial registration number is “ClinicalTrials.gov number, NCT02793180”.

Clinical Pharmacist’s Intervention to Improve Medication Titration for Heart Failure: First Experience from Sudan

“…The study indicated a satisfactory class adherence to ACEIs/ARBs/ARNi, BBs, and MRAs for HFrEF and consistent with previous studies in Sudan and SSA and in Gulf DYSPNEA registry. 7,[21][22][23] Among studied patients, 86%, 93.6%, and 58.2% were prescribed ACEIs/ARBs/ARNi, BBs, and MRAs therapy, respectively (Table 2). Unfortunately, the international registries and our study described good adherence to evidence-based medications also reported use of suboptimal doses, as most patients were not prescribed guideline-recommended target doses of these medications.…”

“…Unfortunately, the international registries and our study described good adherence to evidence-based medications also reported use of suboptimal doses, as most patients were not prescribed guideline-recommended target doses of these medications. 23,24 Clinical pharmacists in HF management have many roles in different settings and through diverse approaches. They can work in inpatients or outpatient's settings, as independent health-care providers or as a part of MD team.…”

“…Unfortunately, the international registries and our study described good adherence to evidence-based medications also reported use of suboptimal doses, as most patients were not prescribed guideline-recommended target doses of these medications. 23 , 24 …”